Table 2 |
|||||
|
Extracellular proteins modulated by chondroitin sulfate treatment in IL-1β-stimulated chondrocytes |
|||||
|
Accession numbera |
Name |
Symbol |
Ratiob |
P value |
Error factorc |
|
|
|||||
|
[P00751] |
Complement factor B |
CFAB |
0.5566 |
0.0064 |
1.397 |
|
[Q08431] |
Lactadherin |
MFGM |
0.597 |
0.0151 |
1.3855 |
|
[Q7Z7G0] |
Target of Nesh-SH3 |
TARSH |
0.7017 |
0.006 |
1.2209 |
|
[P09871] |
Complement C1s subcomponent |
C1S |
0.7085 |
0.0007 |
1.1398 |
|
[P01024] |
Complement C3 |
CO3 |
0.7241 |
0.0023 |
1.1999 |
|
[P02751] |
Fibronectin |
FINC |
0.7321 |
0.0006 |
1.1891 |
|
[P03956] |
Interstitial collagenase |
MMP1 |
0.7113 |
0 |
1.0977 |
|
[P00736] |
Complement C1r subcomponent |
C1R |
0.7734 |
0.0071 |
1.1755 |
|
[P08253] |
72 kDa type IV collagenase |
MMP2 |
0.7759 |
0.0001 |
1.0999 |
|
[P36222] |
Chitinase-3-like protein 1 |
CH3L1 |
0.8088 |
0.0216 |
1.4096 |
|
[P10909] |
Clusterin |
CLUS |
0.8224 |
0.05 |
1.2162 |
|
[P08254] |
Stromelysin-1 |
MMP3 |
0.8256 |
0.0086 |
1.1378 |
|
[P07093] |
Glia-derived nexin |
GDN |
1.2894 |
0.0031 |
1.1664 |
|
[O00391] |
Sulfhydryl oxidase 1 |
QSOX1 |
1.3064 |
0.0382 |
1.2709 |
|
[Q92954] |
Proteoglycan 4 |
PRG4 |
1.4393 |
0.05 |
1.445 |
|
[P98066] |
TNF-inducible gene 6 protein |
TSG6 |
1.7773 |
0.0007 |
1.3371 |
|
[P61769] |
Beta-2-microglobulin |
B2MG |
2.1652 |
0.0125 |
1.4553 |
|
[P07996] |
Thrombospondin-1 |
TSP1 |
89.1678 |
0 |
>2 |
|
|
|||||
|
Extracellular proteins identified by SILAC and liquid chromatography-mass spectrometry analysis as modulated by CS treatment in IL-1β-stimulated chondrocytes. aProtein accession number according to the SwissProt and TrEMBL databases. bAverage SILAC ratios (n = 3) that represent the relative protein abundance in CS-treated versus untreated cells, calculated by Protein Pilot 3.0 software (ABSciex). P ≤ 0.05 was accepted. cError factor of the quantification (measure of the error in the average quantification ratio as calculated by Protein Pilot 3.0 software). |
|||||
|
Calamia et al. Arthritis Research & Therapy 2012 14:R202 doi:10.1186/ar4040 |
|||||